4,673
Participants
Start Date
September 30, 2003
Primary Completion Date
March 31, 2006
Study Completion Date
March 31, 2006
SR34006 (idraparinux sodium) Injection
vitamin K antagonist (warfarin or acenocoumarol) tablets
Cardiology, P.C., Birmingham
Oracle Research, a Division of: The Heart Center, P.C., Huntsville
Arizona Heart Institute Mesa, Mesa
Saguaro Clinical Research, Tucson
Southern Arizona Veterans Affairs Health Care System, Tucson
Office of Dr. Bowden, D.O., Healdsburg
Jerry L. Pettis VA Medical Center, Loma Linda
Kenneth W. Carr, M.D. Cardiology, Oceanside
Richard A. Levy, M.D., San Francisco
Cardiology Specialists of Orange County, Santa Ana
Aurora Denver Cardiology Associates, Aurora
Denver Health and Hospital Authority Adult Medicine Clinic, Denver
Denver Health and Hospital Authority Eastside Health Clinic, Denver
Denver Health Medical Center, Denver
Florida Arrhythmia Consultants, Fort Lauderdale
North Broward Hospital District Cardiovascular Research Institute, Fort Lauderdale
Jacksonville Cardiovascular Clinic, Jacksonville
Jacksonville Center for Clinical Research, Jacksonville
Cardiovascular Center of Sarasota, Sarasota
Wellington Green Family Practice, Wellington
Beacon Medical Research, Indianapolis
Heart & Vascular Clinic/Advanced Medical Research, Covington
The Clinic (Lake Charles Medical & Surgical Clinic), Lake Charles
IMG Healthcare, LLC, New Orleans
Baystate Medical Center, Springfield
New Mexico Heart Institute, PA, Albuquerque
University of New Mexico Hospital, Albuquerque
Practice of James A. Underberg @ Murray Hill Medical Group, New York
Duke University Medical Center, Durham
The Oregon Health and Science University, Portland
Blackstone Cardiology Associates, P.C., Pawtucket
Austin Heart, P.A., Austin
Cardiovascular Research Institute of Dallas, Inc./Cardiology and Internal Medicine Associates, Dallas
South Texas Cardiovascular Consultants, San Antonio
LDS Hospital, Salt Lake City
Physicians Office Building (POB), Salt Lake City
McGuire VA Medical Center, Richmond
Swedish Medical Center, Seattle
Inland Cardiology, Spokane
Marshfield Clinic, Marshfield
St. Joseph's Hospital, Marshfield
Bondi Junction, Cairns, Camperdown, Miranda, Perth
Concord Repartiation General Hospital, Concord
South Australia, Tasmania, Victoria
Cardiology Consultant's Group, Calgary
Foothills Medical Centre, Calgary
Heart Health Institute, Calgary
University of Calgary, Calgary
Dr. M.P.J. Senaratne Professional Corporation, Edmonton
West Coast Cardiology Research, New Westminster
Cardiac Arrhythmia Trials, Victoria
Health Care Corporation of St. John's Health Sciences Centre, St. John's
Zoom International Inc., Saint-Jérôme
Moose Jaw Cardiac Centre, Moose Jaw
Royal University Hospital, Saskatoon
Saskatoon Medical Specialists, Saskatoon
Specialists Internal Medicine, Saskatoon
Dr. Joesph J. Javier, Yorkton
Yorkton Regional Health Centre, Yorkton
Faaborg, Fredericia, Frederiksberg, Frederikshavn, Hellerup
Herlev, Hillerod, Holstebro, Horsens, Kalundborg, Kobenhavn
Kolding, Nykobing Mors, Odense, Skive, Svendborg
Bourg En Bresse, Dreux, Lille, Marseille, Maubeuge, Mulhouse
Nantes, Nice, Paris, Poitiers, Rennes, Saint Denis
Saint-Etienne, Toulouse
"A.O. Instituti Ospitalieri di Cremona", Cremona
Merate, Milano, Padova, Pavia, Piacenza, Reggio Emilia
Azienda Ospedaliera San Paolo, Milan
Azienda Ospedaliera di Parma, Parma
U.O. di Medicina Interna II, Parma
Centro Emostasi e Trombosi, Rimini
Torino, Treviso
Varese
Almelo, Amersfoort, Breda, Boxmeer, Delft, Dordrecht
Eindhoven, Enschede, Gorinchem, Gouda, Groningen, Harderwijk
Heerlen, Hilversum, Rotterdam, Sneek, Spijkenisse, Tiel
Academisch Ziekenhuis Maastricht, Maastricht
Auckland, Christchurch, Hastings
Kielce, Krakow, Opole, Plock, Siedlce, Warszawa, Wroclaw
University Hospital of Wales, Cardiff
Exeter, Dundee, Glasgow, Merseyside, Wirral
University of Glasgow, Glasgow
Freeman Hospital, Newscastle Upon Tyne
New Cross Hospital, Wolverhampton
Lead Sponsor
Sanofi
INDUSTRY